MedTrace Logo

A Three Month Bleeding-Model Clinical Study

NCT05916521 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-06-23

No results posted yet for this study

Summary

The objective of the study is to evaluate the gingivitis control benefit of an established stannous fluoride containing toothpaste relative to a negative control dentifrice.

Conditions

  • Gingivitis

Interventions

DRUG

0.454% stannous fluoride

Brush two times daily

DRUG

0.76% sodium monofluorophosphate

Brush two times daily

DRUG

0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM

Brush two times daily

Sponsors & Collaborators

  • Procter and Gamble

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2022-02-11
Completion
2022-02-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05916521 on ClinicalTrials.gov